EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Effect of Sotagliflozin on Kidney Function and Cardio‐Kidney‐Metabolic Parameters Across Baseline eGFR Subgroups in Patients With Type 2 Diabetes and Stage 4 CKD

Vikas S Sridhar, Luxcia Kugathasan iD, Manon Girard, Michael J Davies, David Z I Cherney iD

Diabetes, Obesity and Metabolism · 2026-12 · 28 (12) · 11966-11970

DOI: 10.1111/dom.71256 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 24.08.2026. Verfasst von Vikas S Sridhar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lexicon Pharmaceutical Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

SGLT inhibitionglomerular filtration ratesotagliflozinstage 4 chronic kidney diseasetype 2 diabetesurine albumin‐to‐creatinine ratio

Autor:innen und Institutionen

  • Department of Medicine, Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Medicine, Division of Nephrology, University Health Network, Toronto, Ontario, Canada.
  • Lexicon Pharmaceuticals, Inc, The Woodlands, Texas, USA.

ORCID-Profile: Luxcia Kugathasan, David Z I Cherney

Förderung

  • Lexicon Pharmaceutical Inc

Zitieren

APA

Sridhar, V. S., Kugathasan, L., Girard, M., Davies, M. J., & Cherney, D. Z. I. (2026). Effect of Sotagliflozin on Kidney Function and Cardio‐Kidney‐Metabolic Parameters Across Baseline eGFR Subgroups in Patients With Type 2 Diabetes and Stage 4 CKD. Diabetes, Obesity and Metabolism, 28(12), 11966-11970. https://doi.org/10.1111/dom.71256

Vancouver

Sridhar VS, Kugathasan L, Girard M, Davies MJ, Cherney DZI. Effect of Sotagliflozin on Kidney Function and Cardio‐Kidney‐Metabolic Parameters Across Baseline eGFR Subgroups in Patients With Type 2 Diabetes and Stage 4 CKD. Diabetes, Obesity and Metabolism. 2026;28(12):11966-11970. doi:10.1111/dom.71256

BibTeX
@article{Sridhar2026,
  author = {Sridhar, Vikas S and Kugathasan, Luxcia and Girard, Manon and Davies, Michael J and Cherney, David Z I},
  title = {Effect of Sotagliflozin on Kidney Function and Cardio‐Kidney‐Metabolic Parameters Across Baseline eGFR Subgroups in Patients With Type 2 Diabetes and Stage 4 CKD},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {12},
  pages = {11966--11970},
  doi = {10.1111/dom.71256}
}
Kostenlos starten →